Therapeutic uses of humanized antibodies against alpha-4...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2237808

The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.

Cette invention concerne des procédés de traitement dans lesquels on utilise des immunoglobulines qui se lient spécifiquement à l'alpha-4 intégrine. Ces procédés sont utiles pour traiter l'asthme, l'athérosclérose, la dégénérescence liée au SIDA, le diabète, la maladie intestinale inflammatoire, la polyarthrite rhumatoïde, le rejet de transplant, la maladie du greffon contre l'hôte, la métastase de tumeur, la néphrite, la dermatite atopique, le psoriasis, l'ischémie du myocarde et les lésions aiguës du poumon à médiation leucocytaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic uses of humanized antibodies against alpha-4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of humanized antibodies against alpha-4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of humanized antibodies against alpha-4... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1608421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.